Madrigal Pharmaceuticals's total assets for Q1 2026 were $1.23B, a decrease of -2.56% from the previous quarter. MDGL total liabilities were $683.87M for the fiscal quarter, a 4.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.